ETONEton Pharmaceuticals, Inc.

Nasdaq etonpharma.com


$ 3.20 $ -0.08 (-2.44 %)    

Wednesday, 24-Apr-2024 10:57:45 EDT
QQQ $ 424.70 $ -3.60 (-0.84 %)
DIA $ 383.57 $ -1.44 (-0.37 %)
SPY $ 503.55 $ -3.01 (-0.59 %)
TLT $ 88.20 $ -0.22 (-0.25 %)
GLD $ 214.95 $ 0.54 (0.25 %)
$ 3.28
$ 3.20
$ 0.00 x 0
$ 0.00 x 0
$ 3.20 - $ 3.20
$ 2.42 - $ 5.81
23,267
na
84.26M
$ 1.29
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-14-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-16-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-16-2022 12-31-2021 10-K
10 11-16-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
12 05-13-2021 03-31-2021 10-Q
13 03-16-2021 12-31-2020 10-K
14 11-12-2020 09-30-2020 10-Q
15 08-12-2020 06-30-2020 10-Q
16 05-14-2020 03-31-2020 10-Q
17 03-05-2020 12-31-2019 10-K
18 11-14-2019 09-30-2019 10-Q
19 08-06-2019 06-30-2019 10-Q
20 05-07-2019 03-31-2019 10-Q
21 03-25-2019 12-31-2018 10-K
22 12-20-2018 09-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

PKU GOLIKE® is a commercial ultra-rare disease medical formula complementary to Eton's existing metabolic franchise and s...

 eton-pharmaceuticals-q4-2023-gaap-eps-009-misses-004-estimate-sales-7313m-miss-7700m-estimate

Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate o...

 earnings-scheduled-for-march-14-2024

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.

 eton-pharmaceuticals-won-us-patent-for-proprietary-hydrocortisone-oral-liquid-formulation

Eton Pharmaceuticals ("Eton" or the "Company") (NASDAQ:ETON), an innovative pharmaceutical company focused on d...

 hc-wainwright--co-reiterates-buy-on-eton-pharmaceuticals-maintains-10-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and maintains $1...

 eton-pharmaceuticals-q3-eps-002-beats-010-estimate-sales-703m-beat-626m-estimate

Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of ...

 earnings-scheduled-for-november-9-2023

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on re...

 eton-pharmaceuticals-announces-acquisition-of-fda-approved-ultra-rare-disease-product-nitisinone

The acquired product was approved by the U.S. Food and Drug Administration (FDA) in May of 2023 for the treatment of hereditary...

 why-maxeon-solar-technologies-are-trading-lower-by-around-32-here-are-other-stocks-moving-in-fridays-mid-day-session

Gainers Amyris, Inc. (NASDAQ: AMRS) shares jumped 179.1% to $0.1839. Amyris shares dipped over 80% on Thursday after the co...

 consolidated-water-spectrum-brands-arco-platform-semler-scientific-and-other-big-stocks-moving-higher-on-friday

U.S. stocks traded mixed, with the Dow Jones gaining around 80 points on Friday. Here are some big stocks recording gains in to...

Core News & Articles

TSAT: 90% | Telesat Corp shares are trading higher after the company reported second-quarter results and tapped MDA under a $2....

 why-semler-scientific-shares-are-trading-higher-by-40-here-are-20-stocks-moving-premarket

Gainers Amyris, Inc. (NASDAQ: AMRS) shares surged 45.4% to $0.0958 in pre-market trading. Amyris shares dipped over 80% on ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION